The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Characterization of Human CD8+ T Cells Reactive with Mycobacterium tuberculosis–infected Antigen-presenting Cells
Open accessAbstract
Previous studies in murine models, including those using the β2 microglobulin knockout mouse, have suggested an important role for CD8+ T cells in host defense to Mycobacterium tuberculosis (Mtb). At present, little is understood about these cells in the human immune response to tuberculosis. This report demonstrates the existence of human Mtb-reactive CD8+ T cells. These cells are present preferentially in persons infected with Mtb and produce interferon γ in response to stimulation with Mtb-infected target cells. Recognition of Mtb-infected cells by these CD8+ T cells is restricted neither by the major histocompatibility complex (MHC) class I A, B, or C alleles nor by CD1, although it is inhibited by anti–MHC class I antibody. The Mtb-specific CD8+ T cells recognize an antigen which is generated in the proteasome, but which does not require transport through the Golgi-ER. The data suggest the possible use of nonpolymorphic MHC class Ib antigen presenting structures other than CD1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We demonstrate that bacterial HLA-I and HLA-II peptides can be presented by both antigen-presenting cells (as has previously been shown25–28) and by melanoma cells”
From Identification of bacteria-derived HLA-bound peptides in melanoma (2021) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,468
Proliferating dendritic cell progenitors in human blood.
Romani, N., Grüner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.1.83 · Cited by 1,841
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,678
Recognition of a lipid antigen by CD1-restricted αβ+ T cells
Beckman, E. M., Porcelli, S. A., Morita, C. T., Behar, S. M., Furlong, S. T., & Brenner, M. B. (1994) · Nature · doi:10.1038/372691a0 · Cited by 977
The global tuberculosis situation and the new control strategy of the World Health Organization
Kochi, A. (1991) · Tubercle · doi:10.1016/0041-3879(91)90017-m · Cited by 849
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. H., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 793
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., DeWitt, C. M., Orme, I. M., Baldwin, S. L., D'Souza, C. D., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 628
Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., & Harding, C. V. (1993) · Nature · doi:10.1038/361359a0 · Cited by 615 · cited 2×
“However, particulate antigens have been shown to gain access to the MHC class I pathway (18, 19), although the efficiency of these pathways remains controversial (20).”
BackgroundKovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 601
CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigen
Porcelli, S. A., Morita, C. T., & Brenner, M. B. (1992) · Nature · doi:10.1038/360593a0 · Cited by 572
Flagged first, then by citations
1 of the 33 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–165 of 165
Coler, R. N., Dillon, D. C., Skeiky, Y. A. W., Kahn, M., Orme, I. M., Lobet, Y., Reed, S. G., & Alderson, M. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.10.056 · Cited by 34
Self-citationVani, J., Shaila, M. S., Chandra, N. R., & Nayak, R. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.09.012 · Cited by 33
Live antigen carriers as tools for improved anti-tuberculosis vaccines
Hess, J. ⁄. R., & Kaufmann, S. H. E. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(98)00132-1 · Cited by 33
Shao, L., Zhang, W., Zhang, S., Chen, C. Y., Jiang, W., Xu, Y., Meng, C., Weng, X., & Chen, Z. W. (2008) · AIDS · doi:10.1097/qad.0b013e3283117f18 · Cited by 32
Lewinsohn, D. A., Lines, R. A., & Lewinsohn, D. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110094 · Cited by 31
Self-citationConradt, P., Hess, J., & Kaufmann, S. H. E. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80077-x · Cited by 31
Malin, A. S., Huygen, K., Content, J., Mackett, M., Brandt, L., Andersen, P. L., Smith, S. M., & Dockrell, H. M. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01323-x · Cited by 30
CD40 Ligand Trimer Enhances the Response of CD8+ T Cells to Mycobacterium tuberculosis
Samten, B., Wizel, B., Shams, H., Weis, S. E., Klucar, P., Wu, S., Vankayalapati, R., Thomas, E. K., Okada, S., Krensky, A. M., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3180 · Cited by 30
Assessment of cell mediated immunogenicity of Mycobacterium leprae-derived antigens
Maeda, Y., Gidoh, M., Ishii, N., Mukai, C., & Makino, M. (2003) · Cellular Immunology · doi:10.1016/s0008-8749(03)00078-9 · Cited by 29
Chaitra, M. G., Shaila, M. S., & Nayak, R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46928-0 · Cited by 29
Quaresma, J. A. S., de Oliveira, M. F. A., Guimarães, Â. C. R., de Brito, E. B., Brito, R. B., Pagliari, C., de Brito, A. C., Xavier, M. B., & Duarte, M. I. S. (2009) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31819f1997 · Cited by 28
Cytotoxic T cells and mycobacteria
Silva, C. L., Bonato, V. L. D., de Lima, K. M. C., Coelho‐Castelo, A. A. M., Faccioli, L. H., Sartori, A., de Souza, A. O., & Leão, S. C. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00099-4 · Cited by 31
Shang, S., Siddiqui, S., Bian, Y., Zhao, J., & Wang, C.-R. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005688 · Cited by 26
Pine, R. I. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452629 · Cited by 25
In vitro control of Mycobacterium bovis by macrophages
Aldwell, F. E., Wedlock, D. N., Slobbe, L. J., Griffin, J. F. T., Buddle, B. M., & Buchan, G. S. (2001) · Tuberculosis · doi:10.1054/tube.2000.0280 · Cited by 26
The immunogenic peptide for Th1 development
Takatsu, K., & Kariyone, A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00209-6 · Cited by 26
Gervassi, A. L., Probst, P., Stamm, W. E., Marrazzo, J. M., Grabstein, K. H., & Alderson, M. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4278 · Cited by 25
Self-citationCross‐presentation of peptides from intracellular pathogens by MHC class I molecules
Blanchard, N., & Shastri, N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05135.x · Cited by 24
Soloski, M. J., Szperka, M. E., Davies, A., & Wooden, S. L. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22426.x · Cited by 21
Topological journey of parasite-derived antigens for presentation by MHC class I molecules
Blanchard, N., & Shastri, N. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.08.004 · Cited by 20
Verma, R. K., Singh, A. K., Mohan, M., Agrawal, A. K., & Misra, A. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.34 · Cited by 18
Klucar, P., Barnes, P. F., Kong, Y., Samten, B., Tvinnereim, A., Spallek, R., Nepom, G. T., Singh, M., & Shams, H. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.05.008 · Cited by 19
Li, D., Gao, G., Li, Z., Sun, W., Li, X., Chen, N., Sun, J., & Yang, Y. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.08.012 · Cited by 17
Tsunetsugu‐Yokota, Y., Tamura, H., Tachibana, M., Ogata, K., Honda, M., & Takemori, T. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.115 · Cited by 16
Aguirre-Blanco, A. M., Lukey, P. T., Cliff, J. M., & Dockrell, H. M. (2007) · Infection and Immunity · doi:10.1128/iai.01611-06 · Cited by 16
Human CD1d Functions as a Transplantation Antigen and a Restriction Element in Mice
Wang, B., Chun, T., Rulifson, I. C., Exley, M. A., Balk, S. P., & Wang, C.-R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3829 · Cited by 16
Kaufmann, S. H. E., & Flynn, J. L. (2004) · doi:10.1128/9781555817657.ch29 · Cited by 16
Interleukin‐15 in Mycobacterial Infection of Antigen‐Presenting Cells
Maeurer, M. J., Seliger, Trinder, Gerdes, & Seitzer (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00593.x · Cited by 15
Wilkinson, K. A., Simsova, M., Schölvinck, E. H., Šebo, P., Leclerc, C., Vordermeier, H. M., Dickson, S. J., Brown, J. R.-M., Davidson, R. N., Pasvol, G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2991-2998.2005 · Cited by 15
Shams, H., Barnes, P. F., Weis, S. E., Klucar, P., & Wizel, B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0403138 · Cited by 13
The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell
Lewinsohn, D. M., & Lewinsohn, D. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869057 · Cited by 13
Self-citationHöhn, H., Kortsik, C., Nilges, K., Necker, A., Freitag, K., Tully, G., Neukirch, C., & Maeurer, M. J. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01307.x · Cited by 13
Why is IFN-γ insufficient to control tuberculosis?
Flynn, J. L. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01611-x · Cited by 13
Cytotoxicity responses to selected ESAT-6 and CFP-10 peptides in tuberculosis
Kumar, M. M., & Raja, A. (2010) · Cellular Immunology · doi:10.1016/j.cellimm.2010.08.004 · Cited by 12
Upregulation of T‐Cell‐Stimulating Activity of Mycobacteria‐Infected Macrophages
Kimura, H. J., Maeda, Y., Takeshita, F., Takaoka, L. E., Matsuoka, M., & Makino, M. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01472.x · Cited by 12
Vaccination strategies to enhance local immunity and protection against Mycobacterium tuberculosis
Klucar, P., Barnes, P. F., Kong, Y., Howard, S. T., Pang, X., Huang, F.-F., Tvinnereim, A., Samten, B., & Shams, H. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.119 · Cited by 11
A Novel Tuberculosis Antigen Identified from Human Tuberculosis Granulomas*
Yang, Y., Jin, D., Hu, S., Zhang, Y., Zheng, X., Zheng, J., Liao, M., Chen, X., Graner, M. W., Liu, H., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.045237 · Cited by 9
Cytolytic T Cells in the Immune Response to Mycobacterium tuberculosis
Stenger, S. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401753382495 · Cited by 9
Mycobacterium bovis-Infected Cervine Alveolar Macrophages Secrete Lymphoreactive Lipid Antigens
Aldwell, F. E., Dicker, B. L., Tatley, F. D. S., Cross, M. F., Liggett, S., Mackintosh, C. G., & Griffin, J. F. T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7003-7009.2000 · Cited by 7
Development of novel tuberculosis vaccines
Hess, J., & Kaufmann, S. H. E. (1999) · Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie · doi:10.1016/s0764-4469(00)87192-9 · Cited by 7
Morinaga, Y., Yanagihara, K., Araki, N., Migiyama, Y., Nagaoka, K., Harada, Y., Yamada, K., Hasegawa, H., Nishino, T., Izumikawa, K., et al. (2012) · Canadian Journal of Microbiology · doi:10.1139/w11-123 · Cited by 6
Davey, M. P., Rosen, H. R., Woody, C. N., Haley, D. P., Kurkinen, J., & Lewinsohn, D. M. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.26058 · Cited by 6
Self-citationGeneration of MR1-Restricted T Cell Clones by Limiting Dilution Cloning of MR1 Tetramer+ Cells
Cansler, M. E., Null, M. D., Meermeier, E. W., Swarbrick, G. M., Lewinsohn, D. M., & Harriff, M. J. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0207-2_15 · Cited by 5
Self-citationRole of T Cell Subsets in the Modulation of Mycobacterium avium Growth within Human Monocytes
Shiratsuchi, H., Krukovets, I., & Ellner, J. J. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1652 · Cited by 5
Shen, J., Hisaeda, H., Chou, B., Yu, Q., Tu, L., & Himeno, K. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.009 · Cited by 4
Mycobacterium chelonae sensitisation induces CD4+‐mediated cytotoxicity against BCG
Ho, P., Zhang, L., Wei, X., & Seah, G. T. (2009) · European Journal of Immunology · doi:10.1002/eji.200838933 · Cited by 3
Rafieiyan, M., Manna, M. L. L., Dieli, F., Caccamo, N., & Badami, G. D. (2025) · Cells · doi:10.3390/cells14241983 · Cited by 2
Immune biomarkers as key targets in managing tuberculosis: A systematic review
Saini, M., Nagarajan, K., Bhardwaj, S., Ghai, R., & Mishra, A. (2025) · Current Proteomics · doi:10.1016/j.curpro.2025.100050 · Cited by 2
Immunobiology of Pediatric Tuberculosis: Lessons Learned and Implications for an Improved TB-Vaccine
Boer, M. C., Lewinsohn, D., & Lancioni, C. (2017) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0037-1607233 · Cited by 2
Self-citationImmunity against Mycobacterium tuberculosis: Defense strategies
Розов, С. М., Popova, N. A., & Дейнеко, Е. В. (2016) · Biology Bulletin Reviews · doi:10.1134/s2079086416060062 · Cited by 1
CD8+ lymphocytes in immunity against tuberculosis
Li, J., Simonson, A. W., & Flynn, J. L. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf268 · Cited by 2
Aetiopathogenesis, immunology and microbiology of tuberculosis
Barreira‐Silva, P., Torrado, E., Nebenzahl-Guimaraes, H., Källenius, G., & Correia‐Neves, M. (2018) · European Respiratory Society eBooks · doi:10.1183/2312508x.10020917 · Cited by 1
Ernst, J. (1999) · Clinical Infectious Diseases · doi:10.1086/515202 · Cited by 1
Rhea, N. C., Susan, L., & Steven, G. (2012) · InTech eBooks · doi:10.5772/29886
Fortschritte in der Impfstoffentwicklung gegen Tuberkulose
Hess, J., & Kaufmann, S. H. E. (1999) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s001030050189
Mucosal immunity against mycobacterial infection
Rahman, M. J. (2010) · DiVA (Stockholm University)
Presentation of lipid antigen: cloning and sequencing equine CDI
Hines, S. A. (2007) · Research Exchange (Washington State University)
M. tuberculosisSomatic Antigen Specific CD8+T cell Responses in BCG-Vaccinated Subjects
Cho, J. E., Cho, S. N., Lee, K. W., Park, S. K., & Cho, S. (2005) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2005.59.3.272
Fortschritte in der Impfstoffentwicklung gegen Tuberkulose
Hess, J., & Kaufmann, H. E. (1999) · Springer eBooks · doi:10.1007/978-3-662-38283-7_125
Correa, A. A. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-10042023-162038
Li, Y., Qiang, Z., Chang, W., Xiao, Y., Guo, L., & Yan, S. (2026) · Vascular Research · doi:10.15302/vr.2025.0005
Masondo, N., Gordon, M. L., & Chiliza, T. E. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1724374
Martino, A. (2006) · Cineca Institutional Research Information System (Tor Vergata University)
Metadata
- Authors
- Lewinsohn, D. M., Alderson, M. R., Briden, A. L., Riddell, S. R., Reed, S. G., & Grabstein, K. H.
- Affiliations
- Infectious Disease Research Institute (US)
- Corresponding author
- Lewinsohn, David M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-05-18
- Volume
- 187
- Issue
- 10
- Pages
- 1633-1640
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2212289
- OpenAlex
- W2111354206
- Cited by
- 165
- References
- 33
- Citations by year
- 2026: 2 · 2025: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 2 · 2016: 6 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 6
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (5T32 HL-07287, T32HL007287)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CD8+ T cells, Mycobacterium tuberculosis, tuberculosis, interferon-gamma, MHC class I restriction, MHC class Ib, antigen presentation, human immune response
- MeSH terms
- Acetylcysteine, Amino Acid Sequence, Animals, Chloroquine, Humans, Lymphocyte Cooperation, Molecular Sequence Data, Mycobacterium tuberculosis, Tuberculosis, Cysteine Proteinase Inhibitors, Antigen Presentation, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review